Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Sebastien Tabruyn

Angiopoietin-2-driven vascular remodeling in airway inflammation

scientific article

Angiopoietin/Tie2 signaling transforms capillaries into venules primed for leukocyte trafficking in airway inflammation

scientific article

Angiostatic activity of the antitumor cytokine interleukin-21.

scientific article published on 30 May 2008

CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells

scientific article published on 04 December 2018

CXCL-8/IL8 Produced by Diffuse Large B-cell Lymphomas Recruits Neutrophils Expressing a Proliferation-Inducing Ligand APRIL.

scientific article published on 6 December 2016

Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance

scientific article published on 10 June 2004

Cellular source and amount of vascular endothelial growth factor and platelet-derived growth factor in tumors determine response to angiogenesis inhibitors

scientific article published on 28 April 2009

Corrigendum: PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin

scientific article published on 01 May 2015

Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer

scientific article published in April 2015

GATA2 is required for lymphatic vessel valve development and maintenance.

scientific article

GSK3732394: a Multi-specific Inhibitor of HIV Entry

scientific article published on 30 September 2019

Genomic Instability Is an Early Event in Aluminium-Induced Tumorigenesis

scientific article published on 07 December 2020

Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL.

scientific article published on 28 August 2007

Intrinsic pro-angiogenic status of cystic fibrosis airway epithelial cells

scientific article published on 16 March 2007

MiR-205 is downregulated in hereditary hemorrhagic telangiectasia and impairs TGF-beta signaling pathways in endothelial cells

scientific article published on 26 June 2013

MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy

scientific article published on 24 April 2013

Molecular pathways of angiogenesis inhibition

scientific article published on 30 January 2007

NF-kappa B: a new player in angiostatic therapy

scientific article published on 19 February 2008

NF-kappaB activation in endothelial cells is critical for the activity of angiostatic agents

scientific article published on 25 August 2009

PAI-1 mediates the antiangiogenic and profibrinolytic effects of 16K prolactin.

scientific article

Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation

scientific article

Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis.

scholarly article

Raloxifene-induced myeloma cell apoptosis: a study of nuclear factor-kappaB inhibition and gene expression signature

scientific article published on 23 February 2006

Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways

scientific article published on 24 March 2007

Sprouty1, a new target of the angiostatic agent 16K prolactin, negatively regulates angiogenesis

scientific article

Suppression of Tumor Invasion and Metastasis by Concurrent Inhibition of c-Met and VEGF Signaling in Pancreatic Neuroendocrine Tumors

scientific article published on February 24, 2012

Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity

scientific article published on 17 October 2016

The angiostatic 16K human prolactin overcomes endothelial cell anergy and promotes leukocyte infiltration via nuclear factor-kappaB activation

scientific article published on 3 April 2007

The antiangiogenic 16K prolactin impairs functional tumor neovascularization by inhibiting vessel maturation

scientific article

The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-kappaB

scientific article published on 05 June 2003

The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0-G1 and the G2-M phases

scientific article published on 03 March 2005

miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization.

scientific article published on 6 February 2014